Abstract
Background: Overweight and obesity have become a public health issue. Lifestyle modifications delivered through mobile devices, especially mobile phones, present an opportunity to support weight loss efforts. However, evidence regarding the effects of mobile apps on other outcomes, such as blood pressure and physical activity (PA), remains limited. Recent studies on this topic require a systematic review and updating, and the active elements that promote behavior change remain unclear.
Objective: The meta-analysis aimed to explore the effects of mobile phone apps on weight-related outcomes (weight, BMI, waist circumference [WC], fat mass, fat mass percentage), behavioral outcomes (moderate-to-vigorous physical activity [MVPA], energy intake), and metabolic outcomes (systolic blood pressure [SBP], diastolic blood pressure [DBP], triglycerides, hemoglobin A1c [HbA1c]) among adults with overweight and obesity. Behavior change techniques (BCTs), the smallest replicable intervention elements, were also identified to clarify the components used in current studies, along with associated resources, including facilitating, boosting, and nudging. In addition, factors influencing the effectiveness of these interventions were explored.
Methods: Six databases (PubMed, Embase, CENTRAL, Web of Science, PsycINFO, and CINAHL) were searched for relevant randomized controlled trials (RCTs) published in English from inception to May 20, 2024. Two independent authors conducted study selection, data extraction, and quality assessment. The effect size of interventions was calculated using the mean difference (MD), and a random-effects model was applied for data analysis. Subgroup and sensitivity analyses were conducted to explore potential influencing factors and identify possible sources of heterogeneity.
Results: A total of 29 studies were included. The results indicated that mobile phone app interventions significantly reduced weight (MD=−1.45 kg, 95% CI −2.01 to −0.89; P<.001), BMI (MD=−0.35 kg/m2, 95% CI −0.57 to −0.13; P=.002), WC (MD=−1.98 cm, 95% CI −3.42 to −0.55; P=.007), fat mass (MD=−1.32 kg, 95% CI −1.94 to −0.69; P<.001), DBP (MD=−1.76 mm Hg, 95% CI −3.47 to −0.04; P=.04), and HbA1c (MD=−0.13%, 95% CI −0.22 to −0.04; P=.005). However, nonsignificant effects were observed for other outcomes. The most frequently used BCTs included 2.3 “self-monitoring of behavior” (n=25), 4.1 “instruction on how to perform the behavior” (n=24), 2.2 “feedback on behavior” (n=20), 1.1 “goal setting (behavior)” (n=19), and 1.4 “action planning” (n=15). Fifty-nine percent of included studies used 3 resource types (ie, facilitating, boosting, and nudging). Subgroup analyses identified combined diet and PA interventions, medium-term intervention duration, and the use of ≥8 BCTs as potential reference interventions for improving outcomes.
Conclusions: This meta-analysis demonstrates that mobile phone app interventions significantly reduce weight, BMI, WC, fat mass, DBP, and HbA1c in adults with overweight and obesity. However, future studies should explore ways to optimize app interventions by incorporating behavior change strategies and resources to further enhance their overall effectiveness.
doi:10.2196/63313
Keywords
Introduction
Overweight and obesity are defined as excessive fat accumulation that can negatively affect health. People with a BMI between 25 and 30 kg/m2 are classified as overweight, while those with a BMI over 30 kg/m2 are classified as obese []. Overweight and obesity have become major public health issues. In 2016, more than 1.9 billion adults were overweight, with approximately 650 million experiencing obesity [], and this number is estimated to affect half of the global population by 2030 []. Obesity is associated with an increased incidence of chronic conditions such as type 2 diabetes and hypertension [], which in turn reduces disease-free years [], quality of life [], and life expectancy []. In addition, obesity imposes a substantial economic burden on nations []. In 2014, the global economic impact of obesity was projected to be US $2.0 trillion, equivalent to 2.8% of the global gross domestic product (GDP) []. Compared with the healthy-weight population, individuals with obesity incur 36% higher average annual health care expenses, including 105% higher prescription costs and 39% higher primary care costs []. Given the health consequences and economic burden associated with obesity, effective interventions are of great importance.
The fundamental approach to addressing overweight and obesity remains a multicomponent behavioral intervention []. However, several barriers exist in implementing lifestyle interventions aimed at weight loss []. A previous systematic review [] has suggested that mobile health (mHealth) apps hold promise for health behavior change. mHealth is defined as “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices” []. In addition, with advancements in technology, the number of mobile phone users has been steadily increasing, and mHealth interventions have the potential to engage large populations at relatively low costs, enhancing the feasibility and accessibility of public health interventions []. Therefore, lifestyle modifications delivered via mobile devices, especially mobile phones, present an opportunity to help people lose weight.
Several meta-analyses have evaluated the effectiveness of mobile phone apps on weight loss in adults [-]. However, these reviews have some limitations. First, most reviews [-] have primarily focused on weight and BMI, while other important outcomes, such as fat mass, blood pressure, and physical activity (PA), have also been reported in original studies. These additional outcomes hold clinical significance and should be included to provide a more comprehensive understanding of the overall effectiveness of mobile app–based interventions. This would offer valuable insights for helping adults with overweight and obesity prevent obesity-related comorbidities. Second, with the rapid development of technology in recent years, numerous new randomized controlled trials (RCTs) have emerged [-], necessitating updated evidence. Third, although behavioral interventions are the cornerstone of weight loss, the specific components used in these interventions have not been fully examined from the perspective of behavior change [,].
Behavior change techniques (BCTs) are the smallest replicable intervention elements designed to modify or redirect the causal mechanisms that regulate behavior [,]. BCTs are widely used to guide and understand intervention design, and identifying the resources associated with these BCTs is crucial for understanding their functional mechanisms []. To address this, Michaelsen et al [] proposed a behavior change resource model (BCRM) centered on an individual’s resources to elucidate the resources used to form these BCTs. This model categorizes BCTs into 3 types: facilitating, boosting, and nudging, which correspond to external resource provision, reflective resource build-up, and affective resource use, respectively. To the best of our knowledge, no review has yet identified the resources used in mobile app–based behavior change interventions.
Therefore, we aimed to conduct a systematic review and meta-analysis to explore the effects of mobile phone apps on weight-related outcomes (weight, BMI, waist circumference [WC], fat mass, and fat mass percentage), behavioral outcomes (moderate-to-vigorous physical activity [MVPA] and energy intake), and metabolic outcomes (systolic blood pressure [SBP], diastolic blood pressure [DBP], triglycerides, and hemoglobin A1c [HbA1c]) among adults with overweight and obesity. In addition, we identified the BCTs and behavior change resources (BCRs) used in these interventions. We also explored factors influencing the effectiveness of these interventions.
Methods
Overview
This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [] (the PRISMA checklist is provided in ) and was registered on the International Prospective Register of Systematic Reviews (PROSPERO registration number: CRD42024513381).
Search Strategy
Six databases (ie, PubMed, Embase, CENTRAL, Web of Science, PsycINFO, and CINAHL) were independently searched by 2 authors (SJL and YZ) for relevant RCTs published in English from inception to May 20, 2024. The search strategy was developed by one author (SJL) and confirmed by another author (YZ) according to the PICOS (Participants, Interventions, Comparisons, Outcomes, and Study Design) framework. The key search terms and MeSH (Medical Subject Headings) included obesity, overweight, body weight, mobile apps, mHealth, and apps. The full search strategy is provided in . In addition, we manually searched the references of previously published relevant reviews.
Study Eligibility Criteria
Studies included in this meta-analysis had to meet the following criteria: (1) participants: adults with overweight and obesity aged ≥18 years; (2) intervention: mobile phone apps used as the primary component; (3) comparisons: usual care without mobile phone app interventions or no intervention; (4) outcomes: weight-related outcomes (ie, weight, BMI, WC, fat mass, and fat mass percentage), behavioral outcomes (ie, MVPA and energy intake), and metabolic outcomes (ie, SBP, DBP, triglycerides, and HbA1c); (5) study design: RCTs published in English.
Studies were excluded if they met the following criteria: (1) participants diagnosed with diseases other than obesity; (2) conference articles, letters, reviews, commentaries, or protocols; and (3) unavailable full texts or incomplete relevant data.
Study Selection and Data Extraction
All titles and abstracts of the studies were downloaded and imported into EndNote X9, with duplicates automatically removed. Two investigators (SJL and YZ) independently screened the titles and abstracts based on the eligibility criteria. Subsequently, the full texts of potentially relevant studies were downloaded and reviewed to select the included articles. Reasons for exclusion were recorded. Any disagreements were resolved through consultation with a third author (HMM).
Data regarding paper characteristics (author, year, and country), study design, study population (eg, average age, sex distribution, and baseline BMI), intervention content (eg, intervention duration and brief description of the intervention), comparison content (eg, brief introduction to the comparison), and outcomes were extracted into a predesigned Microsoft Excel by one reviewer (SJL) and checked by a second reviewer (YZ). We did not make any assumptions about missing or unclear information when extracting data to avoid introducing misleading information. Other statistics (eg, 95% CI or SEs) were converted to SD if not available (Cochrane Handbook version 6.4, Chapter 5, 5.7) []. If the units of the outcome measures were not uniform, such as triglycerides measured in mg/dL, we converted them to mmol/L to ensure consistency in units. We used Michie BCT Taxonomy (BCTTv1) to identify the BCTs present in the included studies () []. Intervention and control descriptors in the original RCTs that aligned with BCT definitions were marked with a “✓.” The initial identification of BCTs was performed by 1 reviewer (SJL) and checked and confirmed by another reviewer (YT). Subsequently, we mapped the BCTs used in each study to the corresponding BCRs.
Quality Assessment
Cochrane risk-of-bias version 2 (ROB 2) tool was used to assess the methodological quality of the included RCTs by 2 reviewers (SJL and YZ) independently []. This tool contains 5 domains: the randomization process, deviations from the intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result. Each domain was rated as either low, some concerns, or high risk of bias. An overall judgment was then assigned to each study. A third investigator (HMM) was responsible for resolving any discrepancies during the evaluation process.
Two independent authors (SJL and YZ) used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework to assess the overall quality of evidence. The framework evaluates 5 domains: risk of bias, inconsistency, indirectness, imprecision, and publication bias. Based on these evaluations, the quality of evidence was classified as high, moderate, low, or very low. Any disagreements during this process were resolved by a third reviewer (HMM).
Statistical Analysis
The meta-analysis was performed to evaluate the effectiveness of mobile app interventions on weight loss among adults with overweight and obesity, with forest plots used to visually display the results of individual studies and the overall effect size. Outcomes were pooled in the meta-analysis if change scores from baseline were available, and the number of participants was recorded. The heterogeneity of the data was assessed using the chi-square test and the I2 statistic, with 25%, 50%, and 75% representing low, moderate, and high heterogeneity, respectively []. Review Manager software (version 5.3; Cochrane Collaboration) was used to analyze data. The mean difference (MD) with a 95% CI was used to express the effectiveness of interventions involving mobile apps. A random-effects model was applied for data analysis to obtain more conservative results.
Subgroup analyses were conducted to explore factors, including intervention contents, presence of theory, intervention duration, number of BCTs, and number of BCRs, which may influence the effects of the intervention on weight and help identify possible sources of heterogeneity. Sensitivity analyses were also performed to assess the robustness of the results in R (version 4.4.2; R Foundation for Statistical Computing). Publication bias was evaluated by visual evaluation of funnel plot asymmetry and quantified by Egger test in Stata software (version 15; StataCorp). Publication bias assessment was performed separately for outcome measures included in meta-analyses that incorporated more than 10 original studies (Cochrane Handbook version 6.4, Chapter 13, 13.3) []. In all analyses, P<.05 was considered statistically significant.
Results
Study Selection
The literature search across 6 databases generated 8424 articles, and an additional 2 records were added through hand-searching relevant reviews. After removing duplicates, titles and abstracts of 5427 studies were screened. Subsequently, 120 full texts were reviewed. However, 91 studies were excluded based on the eligibility criteria for the following reasons: wrong populations (n=14), wrong interventions (n=33), wrong control (n=21), wrong outcome (n=8), unavailable data (n=7), wrong study design (n=3), duplicates (n=4), and conference abstract (n=1). A detailed list of exclusions with corresponding reasons can be found in . Finally, a total of 29 studies [-,-] were included in the systematic review and meta-analysis. Details are presented in the PRISMA flowchart in .

Study Characteristics
The details of the study characteristics are listed in . The 29 studies were conducted in Spain [,,], France [], the United Kingdom [-], Korea [,,], India [], Australia [-], China [], Japan [], the United States of America [,-], Belgium [], New Zealand [], and Germany []. Sample sizes ranged from 20 to 650 across the included studies, with the average age ranging from 22 to 55 years. Behavioral theories (ie, social cognitive theory, self-regulatory theory, control theory, operant conditioning, ecological theory, social network theory, transtheoretical model, habit formation theory, social support theory, and behavior self-management theory) were used in the design of the mobile app interventions. The intervention duration ranges from 2 months to 24 months. The intervention contents shared some common features, such as goal setting, social support, self-monitoring, and the use of credible sources. Usual care and no intervention were the primary forms of control groups. Outcome measures included weight-related outcomes (weight, BMI, WC, fat mass, and fat mass percentage), behavioral outcomes (MVPA and energy intake), and metabolic outcomes (SBP, DBP, triglycerides, and HbA1c).
In the 29 included RCTs, 34 BCTs from 13 categories were identified in the intervention group, while 20 BCTs from 9 categories were identified in the control group. The number of BCTs identified per study ranged from 2 to 16 (median 8, mean 8.69, SD 3.79) in the intervention group and from 0 to 14 (median 2) in the control group (see ). The most frequently identified BCTs in the intervention group were: 2.3 “self-monitoring of behavior” (n=25), 4.1 “instruction on how to perform the behavior” (n=24), 2.2 “feedback on behavior” (n=20), 1.1 “goal setting (behavior)” (n=19), and 1.4 “action planning” (n=15). In the control group, the most frequently used BCT was 4.1 “instruction on how to perform the behavior” (n=18). Details are shown in .
| BCT Taxonomy | Intervention group | Control group |
| 1.1 Goal setting (behavior) | 19 (65.5) | 8 (27.6) |
| 1.2 Problem solving | 7 (24.1) | 2 (6.9) |
| 1.3 Goal setting (outcome) | 8 (27.6) | 3 (10.3) |
| 1.4 Action planning | 15 (51.7) | 6 (20.7) |
| 1.5 Review behavior goals | 5 (17.2) | 1 (3.4) |
| 1.7 Review outcome goals | 4 (13.8) | 1 (3.4) |
| 2.1 Monitoring of behavior by others without feedback | 2 (6.9) | 0 (0.0) |
| 2.2 Feedback on behavior | 20 (70.0) | 2 (6.9) |
| 2.3 Self-monitoring of behavior | 25 (86.2) | 7 (24.1) |
| 2.4 Self-monitoring of outcomes of behavior | 14 (48.3) | 4 (13.8) |
| 2.5 Monitoring of outcomes of behavior without feedback | 1 (3.4) | 0 (0.0) |
| 2.6 Biofeedback | 3 (10.3) | 0 (0.0) |
| 2.7 Feedback on outcomes of behavior | 13 (44.8) | 2 (6.9) |
| 3.1 Social support (unspecified) | 16 (55.2%) | 4 (13.8%) |
| 3.2 Social support (practical) | 6 (20.7) | 3 (10.3) |
| 3.3 Social support (emotional) | 5 (17.2) | 1 (3.4) |
| 4.1 Instruction on how to perform the behavior | 24 (82.8) | 18 (62.1) |
| 5.1 Information about health consequences | 7 (24.1) | 5 (17.2) |
| 6.1 Demonstration of the behavior | 3 (10.3) | 1 (3.4) |
| 6.2 Social comparison | 3 (10.3) | 0 (0.0) |
| 7.1 Prompts/cues | 13 (44.8) | 2 (6.9) |
| 8.1 Behavioral practice/rehearsal | 2 (6.9) | 0 (0.0) |
| 8.3 Habit formation | 2 (6.9) | 0 (0.0) |
| 8.7 Graded tasks | 2 (6.9) | 0 (0.0) |
| 10.1 Material incentive (behavior) | 3 (10.3) | 0 (0.0) |
| 10.3 Nonspecific reward | 4 (13.8) | 0 (0.0) |
| 10.4 Social reward | 5 (17.2) | 0 (0.0) |
| 10.8 Incentive (outcome) | 1 (3.4) | 0 (0.0) |
| 10.9 Self-reward | 1 (3.4) | 0 (0.0) |
| 11.2 Reduce negative emotions | 1 (3.4) | 0 (0.0) |
| 11.3 Conserving mental resources | 4 (13.8) | 1 (3.4) |
| 12.5 Adding objects to the environment | 12 (41.4) | 2 (6.9) |
| 14.4 Reward approximation | 1 (3.4) | 0 (0.0) |
| 15.4 Self-talk | 1 (3.4) | 0 (0.0) |
aBCT: behavior change technique
The identified BCTs were categorized into 3 resource types: facilitating, boosting, and nudging (see and ). The specifics of BCRs identified in each study are presented in . Among the 29 included RCTs, 24 studies [-,-,-,-,-,] used facilitating resources, 24 [-,-,-,,-] used boosting resources, and 19 [,,-,-,,,-,] used nudging resources. Fifty-nine percent of the included studies used all 3 types of resources, while only 4 studies [,,,] used 1 resource type.

| Studies | Facilitating | Boosting | Nudging | Total |
| Apiñaniz et al [] | ✓ | ✓ | 2 | |
| Bughin et al [] | ✓ | ✓ | ✓ | 3 |
| Carter et al [] | ✓ | ✓ | ✓ | 3 |
| Choi et al [] | ✓ | ✓ | 2 | |
| Domal et al [] | ✓ | ✓ | 2 | |
| Duncan et al [] | ✓ | ✓ | ✓ | 3 |
| Godino et al [] | ✓ | ✓ | ✓ | 3 |
| Hebden et al [] | ✓ | ✓ | ✓ | 3 |
| Hurkmans et al [] | ✓ | ✓ | 2 | |
| Hutchesson et al [] | ✓ | ✓ | ✓ | 3 |
| Jiang et al [] | ✓ | 1 | ||
| Kliemann et al [] | ✓ | ✓ | 2 | |
| Lugones-Sanchez et al [] | ✓ | ✓ | ✓ | 3 |
| Lugones-Sanchez et al [] | ✓ | ✓ | ✓ | 3 |
| Nakata et al [] | ✓ | ✓ | ✓ | 3 |
| Palacios et al [] | ✓ | 1 | ||
| Patel et al [] | 0 | |||
| Rogers et al [] | ✓ | 1 | ||
| Shin et al [] | ✓ | ✓ | ✓ | 3 |
| Simpson et al [] | ✓ | ✓ | ✓ | 3 |
| Spring et al [] | ✓ | ✓ | ✓ | 3 |
| Thomas et al [] | ✓ | ✓ | ✓ | 3 |
| Vaz et al [] | ✓ | ✓ | ✓ | 3 |
| Whitelock et al [] | ✓ | ✓ | ✓ | 3 |
| Allen et al [] | ✓ | ✓ | ✓ | 3 |
| Ross et al [] | ✓ | ✓ | 2 | |
| Jospe et al [] | ✓ | 1 | ||
| Jin et al [] | 0 | |||
| Gemesi et al [] | ✓ | ✓ | ✓ | 3 |
| Total number of each BCR | 24 | 24 | 19 | 67 |
Risk of Bias and GRADE Assessment
Of the 29 included studies, 10 [-,,-,,,] were judged to have low risk of bias, 4 [,,,] as having some concerns, and 15 [,,,-,,,,,,-] as having high risk of bias (). While all studies reported the use of randomization, 13 studies [,,,,,,,,-,] failed to explain the allocation concealment process, which was considered a high risk in this domain. Other significant sources of bias included high dropout rates with unreported reasons and the absence of appropriate analysis to assess the impact of missing outcome data.

Of the 11 outcomes included, the overall quality of evidence was assessed to be very low to moderate according to the GRADE assessment (). The risk of bias was considered serious based on the results of ROB 2 assessments. Indirectness was not considered serious, as the outcomes were directly measured. No publication bias was detected for any of the outcomes. Inconsistency ranged from not serious to very serious based on the heterogeneity values, and imprecision ranged from not serious to serious, as determined by the 95% CI.
| Outcome | Studies, n/N (%) | Quality assessment | Patients (I/C), n/N | Effect, mean difference (95% CI) | Quality | ||||
| Risk of bias | Inconsistency | Indirectness | Imprecision | Publication bias | |||||
| Weight | 28/29 (97) | Serious | Very Serious | Not serious | Not serious | Undetected | 1743/1680 | −1.45 (−2.01 to −0.89) | Very Low |
| BMI | 18/29 (62) | Serious | Serious | Not serious | Not serious | Undetected | 1241/1216 | −0.35 (−0.57 to −0.13) | Low |
| WC | 12/29 (41) | Serious | Very serious | Not serious | Serious | Undetected | 897/877 | −1.98 (−3.42 to −0.55) | Very Low |
| Fat mass | 10/29 (34) | Serious | Serious | Not serious | Not serious | Undetected | 537/521 | −1.32 (−1.94 to −0.69) | Low |
| Fat mass percentage | 11/29 (38) | Serious | Very serious | Not serious | Not serious | Undetected | 630/632 | −0.40 (−1.00 to 0.19) | Very Low |
| MVPA | 6/29 (21) | Serious | Not serious | Not serious | Serious | Undetected | 319/248 | −0.69 (−5.67 to 4.28) | Low |
| Energy intake | 6/29 (21) | Serious | Very serious | Not serious | Serious | Undetected | 619/573 | −62.72 (−181.62 to 56.18) | Very Low |
| SBP | 9/29 (31) | Serious | Very serious | Not serious | Serious | Undetected | 493/502 | −0.14 (−2.66 to 2.37) | Very Low |
| DBP | 8/29 (28) | Serious | Very serious | Not serious | Not serious | Undetected | 460/469 | −1.76 (−3.47 to −0.04) | Very Low |
| Triglycerides | 6/29 (21) | Serious | Not serious | Not serious | Not serious | Undetected | 294/293 | 0.06 (−0.19 to 0.31) | Moderate |
| HbA1c | 5/29 (17) | Serious | Very serious | Not serious | Not serious | Undetected | 316/275 | −0.13 (−0.22 to −0.04) | Very Low |
aI: intervention group.
bC: control group.
cWC: waist circumference.
dMVPA: moderate-to-vigorous physical activity.
eSBP: systolic blood pressure.
fDBP: diastolic blood pressure.
gHbA1c: hemoglobin A1c.
Effects of Mobile Phone App
The review examined the effects of mobile phone app interventions on weight-related outcomes (weight, BMI, WC, fat mass, and fat mass percentage), behavioral outcomes (MVPA and energy intake), and metabolic outcomes (SBP, DBP, triglycerides, and HbA1c). A summary of the meta-analyses’ results was shown in .
| Outcomes | Studies, n/N (%) | Sample size (intervention group), n | Sample size (control group), n | Mean difference (95% CI) | P value | I2 (%) |
| Weight-related outcomes | ||||||
| Weight (kg) | 28/29 (97) | 1743 | 1680 | −1.45 (−2.01 to −0.89) | <.001 | 56 |
| BMI (kg/m2) | 18/29 (62) | 1241 | 1216 | −0.35 (−0.57 to −0.13) | .002 | 43 |
| WC (cm) | 12/29 (41) | 897 | 877 | −1.98 (−3.42 to −0.55) | .007 | 82 |
| Fat mass (kg) | 10/29 (34) | 537 | 521 | −1.32 (−1.94 to −0.69) | <.001 | 31 |
| Fat mass percentage (%) | 11/29 (38) | 630 | 632 | −0.40 (−1.00 to 0.19) | .18 | 60 |
| Behavioral outcomes | ||||||
| MVPA (mins/day) | 6/29 (21) | 319 | 248 | −0.69 (−5.67 to 4.28) | .78 | 0 |
| Energy intake (kcal/day) | 6/29 (21) | 619 | 573 | −62.72 (−181.62 to 56.18) | .30 | 62 |
| Metabolic outcomes | ||||||
| SBP (mm Hg) | 9/29 (31) | 493 | 502 | −0.14 (−2.66 to 2.37) | .91 | 66 |
| DBP (mm Hg) | 8/29 (28) | 460 | 469 | −1.76 (−3.47 to −0.04) | .04 | 61 |
| Triglycerides (mmol/L) | 6/29 (21) | 294 | 293 | 0.06 (−0.19 to 0.31) | .64 | 9 |
| HbA1c (%) | 5/29 (17) | 316 | 275 | −0.13 (−0.22 to -0.04) | .005 | 82 |
aWC: waist circumference.
bMVPA: moderate-to-vigorous physical activity.
cSBP: systolic blood pressure.
dDBP: diastolic blood pressure.
eHbA1c: hemoglobin A1c.
Weight-Related Outcomes
Weight
Twenty-nine RCTs [-,-] measured weight as an outcome, but 1 study [] was excluded from the meta-analysis due to unavailable outcome data. Therefore, the outcomes of 28 studies involving 1743 participants in the intervention group and 1680 participants in the control group were pooled. The results indicated that mobile phone app interventions significantly reduced weight (MD=−1.45 kg, 95% CI −2.01 to −0.89; P<.001), with modest heterogeneity (Χ2=61.03, df=27, I2=56%), as determined by the random-effects model ().

BMI
Eighteen studies [-,-,,,,-,,,] assessing BMI were included in the meta-analysis. The mobile phone app intervention resulted in a significant reduction in BMI (MD=−0.35 kg/m2, 95% CI −0.57 to −0.13; P=.002), with moderate heterogeneity (Χ2=29.91, df=17, I2=43%; ).
WC
Twelve studies [,,-,-,,,,] with 897 participants in the intervention group were included in the meta-analysis to examine the effects of mobile phone app intervention on WC. The results showed that WC was significantly reduced (MD=−1.98 cm, 95% CI −3.42 to −0.55; P=.007), with high heterogeneity (Χ2=62.49, df=11, I2=82%; ).
Fat Mass
The effect on fat mass was measured by 11 RCTs [,,,,,,,,,,], with a total of 1058 participants pooled for the meta-analysis. Fat mass was significantly reduced (MD=−1.32 kg, 95% CI −1.94 to −0.69; P<.001) due to the mobile app intervention. Heterogeneity was low across the included studies (Χ2=13.11, df=9, I2=31%; ).
Fat Mass Percentage
Eleven RCTs [,,-,,,,,,] were included to examine the effects on fat mass percentage. The mobile app intervention did not lead to a statistically significant reduction in fat mass percentage (MD=−0.40, P=.18, 95% CI −1.00 to 0.19), and the heterogeneity was moderate (Χ2=25.08, df=10, I2=60%; ).
Behavioral Outcomes (MVPA and Energy Intake)
The mobile phone app intervention decreased MVPA, but this change was not statistically significant (MD=−0.69, 95% CI −5.67 to 4.28; P=.78; ). No heterogeneity was observed. When pooling the data on energy intake in the meta-analysis, the results indicated a nonsignificant effect size (MD=−62.72 kcal/day, 95% CI −181.62 to 56.18; P=.30) with moderate heterogeneity (Χ2=13.33, df=5, I2=62%; ).
Metabolic Outcomes (SBP, DBP, Triglycerides, and HbA1c)
SBP was nonsignificantly reduced (MD=−0.14 mm Hg, 95% CI −2.66 to 2.37; P=.91). The mobile phone app intervention significantly decreased DBP (MD=−1.76 mm Hg, 95% CI −3.47 to −0.04; P=.04). It led to a nonsignificant increase in triglyceride levels (MD=0.06 mmol/L, 95% CI −0.19 to 0.31; P=.64). In addition, there was a significant decrease in HbA1c levels (MD=−0.13%, 95% CI −0.22 to −0.04; P=.005), with high heterogeneity (Χ2=22.79, df=4, I2=82%; Figures S7-S10 in -).
Subgroup and Sensitivity Analysis of Weight
Five subgroup analyses were conducted to explore potential factors influencing the effects of the apps, intervention content (single intervention [diet or PA] versus combined intervention [diet+PA]), theory presence (theory-based versus nontheory-based), intervention duration (short-term [≤3 months] versus medium-term [6 months] versus long-term [>6 months]), number of BCRs used (3 resources vs <3 resources), and number of BCTs used (<median [8] vs ≥median [8]).
Among these, the combined intervention demonstrated a greater effect size (MD=−1.82, 95% CI −2.48 to −1.16 kg) compared with the single intervention group (MD=−0.24, 95% CI −1.00 to 0.53 kg), with statistical significance. Regarding intervention duration, the medium-term (6 mo) group exhibited the largest effects (MD=−2.50, 95% CI −3.65 to −1.35 kg), significantly outperforming the other two groups. In addition, the number of BCTs used ≥8 had a greater effect size (MD=−1.83, 95% CI −2.56 to −1.09 kg vs MD=−0.61, 95% CI −1.28 to −0.07 kg; P=.02; ).
| Variables and subgroups | Number of studies | MD (95% CI) | I2(%) | P value of subgroup difference | |
| Intervention contents | .002 | ||||
| 9 | −0.24 (−1.00 to 0.53) | 0 | |||
| 19 | −1.82 (−2.48 to –1.16) | 64 | |||
| Theory | .34 | ||||
| 8 | −0.97 (−1.96 to 0.02) | 0 | |||
| 20 | −1.54 (−2.20 to –0.89) | 65 | |||
| Intervention duration | .04 | ||||
| 14 | −1.12 (−1.61 to −0.62) | 36 | |||
| 10 | −2.50 (−3.65 to −1.35) | 42 | |||
| 4 | −0.47 (−1.65 to 0.71) | 0 | |||
| BCRs | .44 | ||||
| 17 | −1.56 (−2.23 to –0.88) | 67 | |||
| 11 | −1.10 (−2.06 to –0.13) | 14 | |||
| BCTs | .02 | ||||
| 12 | −0.61 (−1.28 to 0.07) | 0 | |||
| 16 | −1.83 (−2.56 to –1.09) | 70 | |||
aMD: mean difference.
bPA: physical activity.
cBCR: behavior change resources.
dBCT: behavior change techniques.
Sensitivity analyses were performed using the leave-one-out and high-risk study exclusion methods. Notably, after excluding one study from the meta-analysis, the weight reduction effect size changed from −1.45 kg (95% CI −2.01 to −0.89) to −1.20 kg (95% CI −1.61 to −0.79), indicating that this study had a relatively significant influence on the overall effect size []. The heterogeneity also decreased, from 56% to 23%. In addition, excluding high-risk studies resulted in a weight reduction of −1.24 kg (95% CI −1.84 to −0.83) and an I2 of 36%. High-risk studies may overestimate the effect size. However, the sensitivity analyses demonstrate that the results are robust, as no statistically significant changes were observed. This specific study and high-risk studies may account for the heterogeneity to some extent.
Publication Bias
Funnel plot and Egger test for publication bias were conducted when a minimum of 10 studies were incorporated into the meta-analysis. No significant publication bias was detected for weight (Egger test, t27=−0.28; P=.78), BMI (Egger test, t17=0.63; P=.54), WC (Egger test, t11=0.10; P=.92), fat mass (Egger test, t9=0.54; P=.61), or fat mass percentage (Egger test, t10=−0.69; P=.51). The funnel plots were displayed in and Figure S11-S14 in -.

Discussion
Principal Findings
A total of 29 RCTs [-,-] were included in this systematic review and meta-analysis, examining 11 outcomes. The results of this review indicated that mobile app interventions significantly reduced weight, BMI, WC, fat mass, DBP, and HbA1c. However, nonsignificant effects were observed for other outcomes, including fat mass percentage, behavioral outcomes (ie, MVPA and energy intake), and metabolic outcomes (ie, SBP and triglycerides). BCTs and BCRs used in the included studies were also identified, with most studies (59%) using 3 resource types (ie, facilitating, boosting, and nudging). In addition, intervention content, duration, and the number of BCTs used were identified as influencing factors through subgroup analyses.
Interpretation of Findings
Effects of Mobile Phone App on Weight-Related Outcomes
The meta-analysis suggested that interventions delivered via mobile phone apps significantly reduced weight among adults with overweight and obesity, which is consistent with findings from previous meta-analyses [,]. Notably, in our meta-analysis, the effect size for weight loss was 1.45 kg, while meta-analyses conducted by Chew et al [] and Antoun et al [] reported weight loss values of 2.55 kg and 1.99 kg, respectively. The main reason for this difference may be that the two aforementioned reviews included interventions involving both mobile phone apps and nonmobile interventions, whereas our meta-analysis focused on studies using interventions delivered solely by mobile apps or applications combined with nonmobile interventions []. This suggests that, compared with app interventions alone, the combination of app interventions with other strategies, such as health coaching, is more effective. Overall, mobile app–based interventions are a promising and cost-effective way of supporting weight loss.
According to the results of the subgroup analyses, the combined intervention group (diet+PA) showed better outcomes than the single intervention group (diet or PA), which is consistent with the results of previous studies [,]. These findings suggest that future researchers should design weight-loss apps targeting both diet and PA, rather than focusing on a single behavior change. Intervention duration is also a significant factor influencing the effects, with the greatest reductions observed in the medium term. This can be explained by the phenomenon where the effects of mobile apps show initial improvements, peak at 6 months, and then gradually decrease due to a decline in behavior change adherence over time. Therefore, the sustainability of weight-loss effects through the effective use of behavior change strategies is crucial for successful weight loss.
High BMI is associated with various conditions, including cardiovascular disease (CVD), certain cancers, and breathing problems []. BMI was also significantly reduced in our meta-analysis. This finding contrasts with the results of a previous meta-analysis [], which may be attributed to the discrepancy in the number of included original studies (18 vs 3). Therefore, our meta-analysis may provide a more comprehensive insight.
WC, a reliable indicator of not only total body fat but also abdominal visceral fat [], is an accurate predictor of disease []. It exhibits superior efficacy as a marker for all-cause mortality, the incidence of cardiovascular disease [], and metabolic syndrome [] compared with BMI [-], which solely represents total body fat mass. This association between WC and these health outcomes can be explained by the cellular mechanisms linking metabolic syndrome to a proinflammatory state, with visceral obesity playing a central role. In addition, visceral obesity disrupts the normal physiological balance of adipokines, insulin resistance, and endothelial dysfunction, creating a proatherogenic state. Therefore, visceral obesity is closely associated with the incidence of cardiovascular disease []. Given the importance of WC in clinical practice, we consider it a critical outcome. However, among the 29 included studies, only 12 (41%) RCTs reported the effects of mobile apps on WC. We recommend incorporating WC as an outcome in future original studies.
After combining data from 12 RCTs in the meta-analysis, WC was significantly reduced through the use of weight loss apps among individuals with overweight and obesity, consistent with a review performed by Cai et al [], but inconsistent with a previous meta-analysis by Chew et al []. This discrepancy may be explained by the fact that only four RCTs were included in Chew et al’s review [] to examine the effects on WC, 2 of which focused on the older population. This may have reduced the effects of mobile phone apps on WC, as basal metabolic rate decreases almost linearly with age [], making it more difficult for older adults to lose weight.
Our meta-analysis also identified fat mass and fat mass percentage as primary outcomes, revealing a significant reduction in fat mass but not in fat mass percentage. This finding suggests that body components other than fat, such as lean muscle mass and bone mass, may have also decreased during the weight loss period. However, these components are crucial for body functions and overall health. Therefore, future research should focus on strategies aimed specifically at fat reduction, such as individualized fat-loss plans and physical fitness training.
Effects of Mobile Phone App on Behavioral and Metabolic Outcomes
Lifestyle modification, including increasing physical activity and restricting calories, is considered the cornerstone of obesity management [,]. Based on the effectiveness of weight loss apps observed in our meta-analysis, it is worth discussing the underlying reasons behind these lifestyle interventions. Surprisingly, an increase in MVPA was not observed, which may be attributed to several factors. Many weight loss apps are designed to help users self-monitor their PA rather than actively encourage PA [,,]. Our review found that using mobile phone apps can reduce energy intake by approximately 100 kcal/day, which may partly explain the effectiveness of weight loss. However, this reduction was not statistically significant. We recommend that behavior change strategies be more thoroughly considered in the design of future mobile app–based interventions.
In our meta-analysis, we explored the effects on four outcomes (ie, SBP, DBP, triglycerides, and HbA1c) and observed significant reductions in DBP and HbA1c. However, these reductions did not result in clinically significant benefits. This phenomenon may be explained by two factors. First, reductions in blood pressure, triglycerides, and HbA1c are influenced by various factors (eg, pharmacological treatment, diet, and PA) and are not solely dependent on weight management. Weight loss mobile apps are not specifically designed to lower blood pressure, triglycerides, or HbA1c. As a result, the intervention strategies within the weight loss app may not be sufficient to meet the requirements for reducing blood pressure, lowering triglycerides, and improving HbA1c levels. Given that individuals with overweight or obesity are at higher risk of developing metabolic syndromes [], the app could be redesigned to better serve the needs of this high-risk population.
Second, while weight reduction was statistically significant in our review, the extent of weight loss may be insufficient to achieve a clinically meaningful reduction in metabolic outcomes [,]. A previous study [] demonstrated that a 5% weight loss significantly decreases plasma concentrations (eg, glucose, insulin, triglycerides, and leptin) of certain risk factors for cardiometabolic disease. A systematic review [] also indicated that for every 10 kg reduction in weight, there is a corresponding decrease of 6.0 mm Hg in SBP and 4.6 mm Hg in DBP levels. However, due to the limited number of RCTs investigating the effects on metabolic outcomes, our meta-analysis is based on a relatively small number of original studies. Given the importance of clinical significance in weight loss, more RCTs that include assessments of metabolic outcomes are needed to clarify the relationship between weight loss and metabolic outcomes.
Interpretation of Findings of BCTs and BCRs
To our knowledge, this is the first review to identify BCRs used in mobile app interventions for adults with overweight and obesity. The classification standards were based on the BCRM proposed by Michaelsen in 2022 []. Our findings indicate that 59% of studies used 3 resource types in their intervention designs, 21% used 2 types, 14% used 1 type, and 2 studies did not use any resources. Standardization of these classification standards is needed for the future, and further exploration of optimal resource combinations is warranted. Based on the results of the subgroup analyses, the group using ≥8 BCTs showed better outcomes than the group using <8 BCTs, suggesting that a higher number of BCTs was associated with better effect sizes to some extent. Future studies should explore more effective combinations of BCTs to enhance their effects.
Strengths and Limitations
Several strengths can be identified in this review. First, a thorough examination of the effects of mobile phone apps on weight loss among adults with overweight and obesity was conducted. Our meta-analysis includes 11 outcomes based on findings from 29 studies. Weight-related outcomes reflect the direct effects of mobile apps, metabolic outcomes provide evidence of the association between weight reduction and health benefits, and behavioral outcomes inform researchers about the extent to which current interventions target diet and PA, offering guidance for future intervention design. This comprehensive set of outcomes offers substantial insights into the current effectiveness and status of mobile apps in weight loss interventions. Second, only RCTs were included in this review, as they are considered the gold standard in clinical research. This selection criterion ensures that our findings are based on high-quality studies, minimizing bias and enhancing the reliability of the results. Third, the BCTs used in the included RCTs were identified. Systematically reviewing the use of BCTs contributes to the standardization of intervention strategies and enhances comparability across studies, especially given the considerable methodological variability in current weight loss interventions. This provides a reference for researchers to replicate, refine, or design new intervention approaches. Fourth, mapping BCTs to BCRs based on the BCRM helps clarify the resources required to implement specific BCTs during intervention design. This approach also supports more tailored and practical intervention strategies by taking into account the resources available to patients, thereby promoting interventions that are both targeted and feasible.
However, there are also some limitations in this study. First, we only included adults with overweight and obesity without pre-existing medical conditions, which may limit the generalizability of the results to broader populations, such as individuals with diabetes or CVD. However, adults with overweight and obesity without medical conditions represent a critical population from the perspective of preventive medicine, as they are at high risk of developing chronic diseases. Early interventions targeting this population group could potentially reduce the burden of future disease onset. Moreover, there are notable differences in intervention responsiveness and health needs between adults with overweight and obesity with and without medical conditions. By including only participants without comorbidities, this study allows for a more focused analysis of lifestyle-based mobile app interventions, without the influence of complex confounding factors such as medication use or the bidirectional interactions between obesity and chronic diseases. This approach allows for a clearer assessment of behavior change outcomes, especially in the identification of BCTs and the associated BCRs. Second, we identified the BCTs and BCRs used in the RCT interventions included in this review. Although interrater agreement in coding the BCTs and resources was high, the coding process inherently involves a degree of subjectivity, which may influence the results related to BCTs and BCRs. Furthermore, given the relatively limited app of the BCRM in previous research, standardized procedures for mapping BCTs to corresponding resources have not yet been established. The mapping criteria proposed in this study, therefore, require further testing and validation in future research. Finally, the effectiveness of weight loss was influenced not only by the quantity of BCTs and resources used but also by their quality, including factors such as the intensity, frequency, and tailoring of interventions to individual needs. As a result, no meta-regression was conducted to link specific BCTs or BCRs to their effectiveness. We advocate for the conducting of more RCTs to better clarify the specific effects of individual BCT or BCR.
Conclusions
This meta-analysis presents findings that demonstrate that mobile phone app interventions significantly reduce weight, BMI, WC, fat mass, DBP, and HbA1c among adults with overweight and obesity. These mobile phone app interventions are cost-effective and can be applied to a large population. However, current mobile apps have not achieved clinically significant weight loss. Future studies should focus on optimizing app interventions by incorporating more effective behavior change strategies and resources to enhance their overall effectiveness.
Acknowledgments
This study was funded by the Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences (grant 2023-RC320-01).
Data Availability
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request. Generative AI was used to proofread this manuscript to enhance its readability and clarity. The use of AI tools was aimed at improving the overall flow and presentation of the text without altering the original meaning or content.
Authors' Contributions
SJL contributed to conceptualization, methodology, original draft preparation, and review and editing of the manuscript. Y Zhou was involved in conceptualization, methodology, and data curation. YT contributed to software development, data curation, and formal analysis. Haoming Ma was responsible for methodology, software development, and data curation. Y Zhang contributed to the review and editing of the manuscript. AW was involved in conceptualization. XT contributed to methodology and software development. RP contributed to methodology and software development. MHP was involved in conceptualization, methodology, formal analysis, supervision, and the review and editing of the manuscript.
Conflicts of Interest
None declared.
Search strategy.
DOCX File, 16 KBTaxonomy of behavioral change techniques.
PDF File, 189 KBReasons for exclusion of studies.
DOCX File, 35 KBCharacteristics of the included studies.
DOCX File, 93 KBBehavioral change techniques identified in each study.
DOCX File, 48 KBMapping behavioral change techniques to behavioral change resources.
DOCX File, 18 KBMeta-analysis of BMI.
PDF File, 822 KBMeta-analysis of waist circumference.
PDF File, 608 KBMeta-analysis of fat mass.
PDF File, 546 KBMeta-analysis of fat mass percentage.
PDF File, 588 KBMeta-analysis of moderate-to-vigorous physical activity.
PDF File, 417 KBMeta-analysis of energy intake.
PDF File, 493 KBMeta-analysis of systolic blood pressure.
PDF File, 519 KBMeta-analysis of diastolic blood pressure.
PDF File, 477 KBMeta-analysis of triglycerides.
PDF File, 395 KBMeta-analysis of hemoglobin A1c.
PDF File, 380 KBFunnel plot of BMI.
PDF File, 58 KBFunnel plot of fat mass percentage.
PDF File, 58 KBFunnel plot of waist circumference.
PDF File, 58 KBFunnel plot of fat mass.
PDF File, 58 KBPRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist.
PDF File, 160 KBReferences
- Obesity and overweight. WHO. 2021. URL: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight [Accessed 2025-07-02]
- GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. Jul 6, 2017;377(1):13-27. [CrossRef] [Medline]
- Richard Dobbs CS, Thompson F. Overcoming Obesity: An Initial Economic Analysis. McKinsey Global Institute; 2014.
- Nyberg ST, Batty GD, Pentti J, et al. Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study. Lancet Public Health. Oct 2018;3(10):e490-e497. [CrossRef] [Medline]
- Stephenson J, Smith CM, Kearns B, Haywood A, Bissell P. The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study. BMC Public Health. Nov 3, 2021;21(1):1990. [CrossRef] [Medline]
- Vidra N, Trias-Llimós S, Janssen F. Impact of obesity on life expectancy among different European countries: secondary analysis of population-level data over the 1975-2012 period. BMJ Open. Jul 31, 2019;9(7):e028086. [CrossRef] [Medline]
- Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. Apr 19, 2017;14(4):28422077. [CrossRef] [Medline]
- Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes Metab Syndr Obes. Aug 30, 2010;3(285-95):285-295. [CrossRef] [Medline]
- Lagerros YT, Rössner S. Obesity management: what brings success? Therap Adv Gastroenterol. Jan 2013;6(1):77-88. [CrossRef] [Medline]
- de Jong M, Jansen N, van Middelkoop M. A systematic review of patient barriers and facilitators for implementing lifestyle interventions targeting weight loss in primary care. Obes Rev. Aug 2023;24(8):e13571. [CrossRef] [Medline]
- Arroyo AC, Zawadzki MJ. The implementation of behavior change techniques in mHealth apps for sleep: systematic review. JMIR Mhealth Uhealth. Apr 4, 2022;10(4):e33527. [CrossRef] [Medline]
- MHealth: new horizons for health through mobile technologie. WHO. 2011. URL: https://www.afro.who.int/publications/mhealth-new-horizons-health-through-mobile-technologie [Accessed 2025-07-02]
- Yang Q, Van Stee SK. The comparative effectiveness of mobile phone interventions in improving health outcomes: meta-analytic review. JMIR Mhealth Uhealth. Apr 3, 2019;7(4):e11244. [CrossRef] [Medline]
- Antoun J, Itani H, Alarab N, Elsehmawy A. The effectiveness of combining nonmobile interventions with the use of smartphone apps with various features for weight loss: systematic review and meta-analysis. JMIR Mhealth Uhealth. Apr 8, 2022;10(4):e35479. [CrossRef] [Medline]
- Cai X, Qiu S, Luo D, Wang L, Lu Y, Li M. Mobile application interventions and weight loss in type 2 diabetes: a meta-analysis. Obesity (Silver Spring). Mar 2020;28(3):502-509. [CrossRef] [Medline]
- Chew HSJ, Rajasegaran NN, Chin YH, Chew WSN, Kim KM. Effectiveness of combined health coaching and self-monitoring apps on weight-related outcomes in people with overweight and obesity: systematic review and meta-analysis. J Med Internet Res. Apr 18, 2023;25:e42432. [CrossRef] [Medline]
- Hutchesson MJ, Rollo ME, Krukowski R, et al. eHealth interventions for the prevention and treatment of overweight and obesity in adults: a systematic review with meta-analysis. Obes Rev. May 2015;16(5):376-392. [CrossRef] [Medline]
- Neve M, Morgan PJ, Jones PR, Collins CE. Effectiveness of web-based interventions in achieving weight loss and weight loss maintenance in overweight and obese adults: a systematic review with meta-analysis. Obes Rev. Apr 2010;11(4):306-321. [CrossRef] [Medline]
- Choi JH, Kim SW, Seo J, et al. Effects of a mobile-health exercise intervention on body composition, vascular function, and autonomic nervous system function in obese women: a randomized controlled trial. J Multidiscip Healthc. 2023;16(1601-15):1601-1615. [CrossRef] [Medline]
- Domal SV, Chandrasekaran B, Palanisamy HP. Influence of smartphone-based physical activity intervention on executive functions and cardiometabolic disease risk in obese young adults: a pilot randomised controlled trial. J Diabetes Metab Disord. Jun 2023;22(1):619-628. [CrossRef] [Medline]
- Lugones-Sanchez C, Recio-Rodriguez JI, Agudo-Conde C, et al. Long-term effectiveness of a smartphone app combined with a smart band on weight loss, physical activity, and caloric intake in a population with overweight and obesity (evident 3 study): randomized controlled trial. J Med Internet Res. Feb 1, 2022;24(2):e30416. [CrossRef] [Medline]
- Nakata Y, Sasai H, Gosho M, et al. A smartphone healthcare application, CALO mama Plus, to promote weight loss: a randomized controlled trial. Nutrients. Nov 2, 2022;14(21):4608. [CrossRef] [Medline]
- Patel ML, Cleare AE, Smith CM, Rosas LG, King AC. Detailed versus simplified dietary self-monitoring in a digital weight loss intervention among racial and ethnic minority adults: fully remote, randomized pilot study. JMIR Form Res. Dec 13, 2022;6(12):e42191. [CrossRef] [Medline]
- Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. Aug 2013;46(1):81-95. [CrossRef] [Medline]
- Carey RN, Connell LE, Johnston M, et al. Behavior change techniques and their mechanisms of action: a synthesis of links described in published intervention literature. Ann Behav Med. Jul 17, 2019;53(8):693-707. [CrossRef] [Medline]
- Michaelsen MM, Esch T. Functional mechanisms of health behavior change techniques: a conceptual review. Front Psychol. 2022;13(725644):725644. [CrossRef] [Medline]
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. Mar 29, 2021;372:n71. [CrossRef] [Medline]
- Chandler J, Cumpston M, Li T, Page MJ. Welch VA, editor. Cochrane Handbook for Systematic Reviews of Interventions Version. Vol 6. 2023:4.
- Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Higgins JT, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 65. Cochrane; 2024.
- Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. Sep 6, 2003;327(7414):557-560. [CrossRef] [Medline]
- Apiñaniz A, Cobos-Campos R, Sáez de Lafuente-Moríñigo A, et al. Effectiveness of randomized controlled trial of a mobile app to promote healthy lifestyle in obese and overweight patients. Fam Pract. Nov 18, 2019;36(6):699-705. [CrossRef] [Medline]
- Lugones-Sanchez C, Sanchez-Calavera MA, Repiso-Gento I, et al. Effectiveness of an mHealth intervention combining a smartphone app and smart band on body composition in an overweight and obese population: randomized controlled trial (EVIDENT 3 study). JMIR Mhealth Uhealth. Nov 26, 2020;8(11):e21771. [CrossRef] [Medline]
- Bughin F, Bui G, Ayoub B, et al. Impact of a mobile telerehabilitation solution on metabolic health outcomes and rehabilitation adherence in patients with obesity: randomized controlled trial. JMIR Mhealth Uhealth. Dec 6, 2021;9(12):e28242. [CrossRef] [Medline]
- Carter MC, Burley VJ, Nykjaer C, Cade JE. Adherence to a smartphone application for weight loss compared to website and paper diary: pilot randomized controlled trial. J Med Internet Res. Apr 15, 2013;15(4):e32. [CrossRef] [Medline]
- Kliemann N, Croker H, Johnson F, Beeken RJ. Development of the top tips habit-based weight loss app and preliminary indications of its usage, effectiveness, and acceptability: mixed-methods pilot study. JMIR Mhealth Uhealth. May 10, 2019;7(5):e12326. [CrossRef] [Medline]
- Simpson SA, Matthews L, Pugmire J, et al. An app-, web- and social support-based weight loss intervention for adults with obesity: the “HelpMeDoIt!” feasibility randomised controlled trial. Pilot Feasibility Stud. 2020;6(1):133. [CrossRef] [Medline]
- Whitelock V, Kersbergen I, Higgs S, Aveyard P, Halford JCG, Robinson E. A smartphone based attentive eating intervention for energy intake and weight loss: results from a randomised controlled trial. BMC Public Health. May 21, 2019;19(1):611. [CrossRef] [Medline]
- Shin DW, Yun JM, Shin JH, et al. Enhancing physical activity and reducing obesity through smartcare and financial incentives: A pilot randomized trial. Obesity (Silver Spring). Feb 2017;25(2):302-310. [CrossRef] [Medline]
- Jin T, Kang G, Song S, et al. The effects of dietary self-monitoring intervention on anthropometric and metabolic changes via a mobile application or paper-based diary: a randomized trial. Nutr Res Pract. Dec 2023;17(6):1238-1254. [CrossRef] [Medline]
- Duncan MJ, Fenton S, Brown WJ, et al. Efficacy of a multi-component m-Health weight-loss intervention in overweight and obese adults: a randomised controlled trial. Int J Environ Res Public Health. Aug 26, 2020;17(17):6200. [CrossRef] [Medline]
- Hebden L, Cook A, van der Ploeg HP, King L, Bauman A, Allman-Farinelli M. A mobile health intervention for weight management among young adults: a pilot randomised controlled trial. J Hum Nutr Diet. Aug 2014;27(4):322-332. [CrossRef] [Medline]
- Hutchesson MJ, Callister R, Morgan PJ, et al. A targeted and tailored eHealth weight loss program for young women: the be positive be healthe randomized controlled trial. Healthcare (Basel). May 2, 2018;6(2):39. [CrossRef] [Medline]
- Jiang W, Huang S, Ma S, et al. Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial. Nutr Metab (Lond). Feb 3, 2021;18(1):17. [CrossRef] [Medline]
- Godino JG, Merchant G, Norman GJ, et al. Using social and mobile tools for weight loss in overweight and obese young adults (Project SMART): a 2 year, parallel-group, randomised, controlled trial. Lancet Diabetes Endocrinol. Sep 2016;4(9):747-755. [CrossRef] [Medline]
- Palacios C, Torres M, López D, Trak-Fellermeier MA, Coccia C, Pérez CM. Effectiveness of the nutritional app “MyNutriCart” on food choices related to purchase and dietary behavior: a pilot randomized controlled trial. Nutrients. Dec 12, 2018;10(12):1967. [CrossRef] [Medline]
- Rogers RJ, Lang W, Barone Gibbs B, et al. Applying a technology-based system for weight loss in adults with obesity. Obes Sci Pract. Mar 2016;2(1):3-12. [CrossRef] [Medline]
- Spring B, Pellegrini CA, Pfammatter A, et al. Effects of an abbreviated obesity intervention supported by mobile technology: The ENGAGED randomized clinical trial. Obesity (Silver Spring). Jul 2017;25(7):1191-1198. [CrossRef] [Medline]
- Thomas JG, Raynor HA, Bond DS, et al. Weight loss in Weight Watchers Online with and without an activity tracking device compared to control: A randomized trial. Obesity (Silver Spring). Jun 2017;25(6):1014-1021. [CrossRef] [Medline]
- Vaz CL, Carnes N, Pousti B, Zhao H, Williams KJ. A randomized controlled trial of an innovative, user-friendly, interactive smartphone app-based lifestyle intervention for weight loss. Obes Sci Pract. Oct 2021;7(5):555-568. [CrossRef] [Medline]
- Allen JK, Stephens J, Dennison Himmelfarb CR, Stewart KJ, Hauck S. Randomized controlled pilot study testing use of smartphone technology for obesity treatment. J Obes. 2013;2013(151597):151597. [CrossRef] [Medline]
- Ross KM, Wing RR. Impact of newer self-monitoring technology and brief phone-based intervention on weight loss: A randomized pilot study. Obesity (Silver Spring). Aug 2016;24(8):1653-1659. [CrossRef] [Medline]
- Hurkmans E, Matthys C, Bogaerts A, Scheys L, Devloo K, Seghers J. Face-to-face versus mobile versus blended weight loss program: randomized clinical trial. JMIR Mhealth Uhealth. Jan 11, 2018;6(1):e14. [CrossRef] [Medline]
- Jospe MR, Roy M, Brown RC, et al. The effect of different types of monitoring strategies on weight loss: a randomized controlled trial. Obesity (Silver Spring). Sep 2017;25(9):1490-1498. [CrossRef] [Medline]
- Gemesi K, Winkler S, Schmidt-Tesch S, Schederecker F, Hauner H, Holzapfel C. Efficacy of an app-based multimodal lifestyle intervention on body weight in persons with obesity: results from a randomized controlled trial. Int J Obes (Lond). Jan 2024;48(1):118-126. [CrossRef] [Medline]
- Schoeppe S, Alley S, Van Lippevelde W, et al. Efficacy of interventions that use apps to improve diet, physical activity and sedentary behaviour: a systematic review. Int J Behav Nutr Phys Act. Dec 2016;13(1):27927218. [CrossRef]
- Elliot CA, Hamlin MJ. Combined diet and physical activity is better than diet or physical activity alone at improving health outcomes for patients in New Zealand’s primary care intervention. BMC Public Health. Feb 8, 2018;18(1):230. [CrossRef] [Medline]
- Avenell A, Brown TJ, McGee MA, et al. What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions. J Human Nutrition Diet. Aug 2004;17(4):293-316. [CrossRef]
- Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes (Lond). Jun 2021;45(6):1249-1258. [CrossRef] [Medline]
- Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the “beef”? Int J Obes (Lond). Oct 2007;31(10):1552-1553. [CrossRef] [Medline]
- Lofgren I, Herron K, Zern T, et al. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. J Nutr. May 2004;134(5):1071-1076. [CrossRef] [Medline]
- Lee CMY, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. Jul 2008;61(7):646-653. [CrossRef] [Medline]
- Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. Jul 3, 2007;116(1):39-48. [CrossRef] [Medline]
- Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. Nov 13, 2008;359(20):2105-2120. [CrossRef] [Medline]
- Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. Apr 1, 2008;117(13):1658-1667. [CrossRef] [Medline]
- van den Brandt PA, Goldbohm RA. Nutrition in the prevention of gastrointestinal cancer. Best Pract Res Clin Gastroenterol. 2006;20(3):589-603. [CrossRef] [Medline]
- Ritchie SA, Connell JMC. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. May 2007;17(4):319-326. [CrossRef] [Medline]
- Chew HSJ, Koh WL, Ng J, Tan KK. Sustainability of weight loss through smartphone apps: systematic review and meta-analysis on anthropometric, metabolic, and dietary outcomes. J Med Internet Res. Sep 21, 2022;24(9):e40141. [CrossRef] [Medline]
- Zampino M, AlGhatrif M, Kuo PL, Simonsick EM, Ferrucci L. Longitudinal changes in resting metabolic rates with aging are accelerated by diseases. Nutrients. Oct 7, 2020;12(10):3061. [CrossRef] [Medline]
- Jacob JJ, Isaac R. Behavioral therapy for management of obesity. Indian J Endocrinol Metab. Jan 2012;16(1):28-32. [CrossRef] [Medline]
- Strasser B. Physical activity in obesity and metabolic syndrome. Ann N Y Acad Sci. Apr 2013;1281(1):141-159. [CrossRef] [Medline]
- Magkos F, Fraterrigo G, Yoshino J, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. Apr 12, 2016;23(4):591-601. [CrossRef] [Medline]
- Kompaniyets L, Freedman DS, Belay B, et al. Probability of 5% or greater weight loss or BMI reduction to healthy weight among adults with overweight or obesity. JAMA Netw Open. Aug 1, 2023;6(8):e2327358. [CrossRef] [Medline]
- Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. Jun 2017;6(2):187-194. [CrossRef] [Medline]
- Aucott L, Poobalan A, Smith WCS, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension. Jun 2005;45(6):1035-1041. [CrossRef] [Medline]
Abbreviations
| BCR: behavior change resource |
| BCRM: behavior change resource model |
| BCT: Behavior change techniques |
| CVD: cardiovascular disease |
| DBP: diastolic blood pressure |
| GDP: gross domestic product |
| GRADE framework: Grading of Recommendations, Assessment, Development, and Evaluation |
| HbA1c: hemoglobin A1c |
| MD: mean difference |
| MeSH: Medical Subject Headings |
| mHealth: mobile health |
| MVPA: moderate-to-vigorous physical activity |
| PA: physical activity |
| PICOS : Participants, Interventions, Comparisons, Outcomes, and Study Design framework |
| PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROSPERO: Prospective Register of Systematic Reviews |
| RCT: randomized controlled trial |
| ROB 2: Cochrane risk-of-bias version 2 |
| SBP: systolic blood pressure |
| WC: waist circumference |
Edited by Lorraine Buis; submitted 17.06.24; peer-reviewed by Alexios Batrakoulis, Jiayue Xia, Nooshin Noshadi; final revised version received 22.05.25; accepted 30.05.25; published 19.08.25.
Copyright© Sijia Li, You Zhou, Ying Tang, Haoming Ma, Yuying Zhang, Aoqi Wang, Xingyi Tang, Runyuan Pei, Meihua Piao. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 19.8.2025.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.

